News & Updates

OMDI shows potential as first-line treatment for glaucoma in real-world trial

24 May 2022 by

In a retrospective review of real-world data from Japan, omidenepag isopropyl 0.002% ophthalmic solution (OMDI) demonstrated an intraocular pressure (IOP)-lowering effect in eyes with different types of glaucoma, without severe or serious adverse effects.

OMDI shows potential as first-line treatment for glaucoma in real-world trial

24 May 2022

Coffee drinkers at high risk of primary open-angle glaucoma

12 May 2022

A recent Mendelian randomization study has provided evidence that increased coffee intake can put individuals at higher risk of developing primary open-angle glaucoma, a study reports.

Coffee drinkers at high risk of primary open-angle glaucoma

12 May 2022

Diabetic retinopathy in T1DM linked to HbA1c, albuminuria, HDL cholesterol

12 May 2022

The incidence of diabetic retinopathy and its progression in patients with type 1 diabetes mellitus (T1DM) is still high, especially in the presence of high HbA1c, albuminuria, and low high-density lipoprotein (HDL) cholesterol levels, as reported in a study.

Diabetic retinopathy in T1DM linked to HbA1c, albuminuria, HDL cholesterol

12 May 2022

Natamycin still best bet for treating fungal keratitis

11 May 2022 by

In the treatment of patients with filamentous fungal keratitis, natamycin performs better than chlorhexidine, being associated with more favourable outcomes, including visual acuity, and fewer adverse events, as shown in a study.

Natamycin still best bet for treating fungal keratitis

11 May 2022

Fluocinolone acetonide implant safe, effective in the long run

08 May 2022

A fluocinolone acetonide implant shows good tolerability and safety profile over ≥3 years of follow-up, yielding only predictable and manageable events, according to a study.

Fluocinolone acetonide implant safe, effective in the long run

08 May 2022

UWFA detects more retinal capillary nonperfusion in temporal quadrant

05 May 2022

Ultra-widefield angiography (UWFA) is able to identify more retinal capillary nonperfusion (RCNP) than conventional fundus fluorescein angiography, particularly in the temporal quadrant. Of note, large increases in RCNP over 100 weeks of follow-up seeme to be uncommon.

UWFA detects more retinal capillary nonperfusion in temporal quadrant

05 May 2022

Machine learning shows potential in detection of age-related macular degeneration

04 May 2022

Existing machine learning classifiers for age-related macular degeneration (AMD) demonstrate promising diagnostic accuracy, reports a recent meta-analysis.

Machine learning shows potential in detection of age-related macular degeneration

04 May 2022

Adalimumab confers favourable long-term outcome in uveitis

19 Apr 2022 by

In the treatment of patients with uveitis, adalimumab delivers long-term efficacy while having an acceptable side-effect profile, according to real-world data.